Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03860311 · ClinicalTrials.gov registry record · NA
BULLET: Bladder Ultrasound Limits Length (of Time), Expedites Treatment
A NA study of Point-of-Care Bladder Ultrasound and Urethral Catheter, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT03860311 is a NA study of Point-of-Care Bladder Ultrasound and Urethral Catheter that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 45 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03860311, a NA study of Point-of-Care Bladder Ultrasound and Urethral Catheter, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study patients presenting to the pediatric ER with abdominal or pelvic complaints will be randomized to urethral bladder catheter or bladder ultrasound to compare time to completion of successful pelvic ultrasound, as determined by full visualization of uterus and ovaries.
Conditions Studied
Interventions
- OTHER Standard of Care
- DEVICE Bladder Ultrasound
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2019-07-20 |
| Est. Completion | 2021-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03860311
The ClinicalTrials.gov registry entry for NCT03860311 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Point-of-Care Bladder Ultrasound appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT03860311 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT03860311 about?
NCT03860311 is a clinical study titled "BULLET: Bladder Ultrasound Limits Length (of Time), Expedites Treatment". In this study patients presenting to the pediatric ER with abdominal or pelvic complaints will be randomized to urethral bladder catheter or bladder ultrasound to compare time to completion of successful pelvic ultrasound, as determined by full visualization of uterus and ovaries.
What is the current status of trial NCT03860311?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2019-07-20. Estimated completion is 2021-05-01.
What conditions does trial NCT03860311 study?
This clinical trial studies the following conditions: Point-of-Care Bladder Ultrasound, Urethral Catheter.
What interventions are being tested in trial NCT03860311?
The interventions under investigation include: Standard of Care (OTHER), Bladder Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT03860311?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03860311 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.